Estrogen related receptor alpha: Potential modulator of age-related macular degeneration.


Journal

Current opinion in pharmacology
ISSN: 1471-4973
Titre abrégé: Curr Opin Pharmacol
Pays: England
ID NLM: 100966133

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 30 11 2023
revised: 26 01 2024
accepted: 28 01 2024
pubmed: 7 3 2024
medline: 7 3 2024
entrez: 6 3 2024
Statut: ppublish

Résumé

To develop effective therapies for complex blinding diseases such as age-related macular degeneration (AMD), identification of mechanisms involved in its initiation and progression is needed. The estrogen-related receptor alpha (ESRRA) is an orphan nuclear receptor that regulates several AMD-associated pathogenic pathways. However, it has not been investigated in detail in the ocular posterior pole during aging or in AMD. This review delves into the literature highlighting the significance of ESRRA as a molecular target that may be important in the pathobiology of AMD, and discusses data available supporting the targeting of this receptor signaling pathway as a therapeutic option for AMD.

Identifiants

pubmed: 38447458
pii: S1471-4892(24)00009-2
doi: 10.1016/j.coph.2024.102439
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102439

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fatima Massare Somers (FM)

Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA.

Goldis Malek (G)

Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA; Department of Pathology, Duke University School of Medicine, Durham, NC, USA. Electronic address: gmalek@duke.edu.

Classifications MeSH